Clinical efficacy of mirabegron in the treatment of female patients with Parkinson’s disease and overactive bladder
Objective: To compare short-term clinical outcomes and adverse events associated with mirabegron and tolterodine treatment in female patients with Parkinson’s disease (PD) and overactive bladder (OAB). Methodology: This retrospective cohort analysis included 90 female patients with PD and OAB treated in Huzhou Third Mu...